Search results
Showing results for
2023 graduate Claire Lewis shares her experience of the MSc Radiobiology programme and how it has paved the way for her journey into paediatric cancer research.
Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study.
Journal article
Jackson A. et al, (2026), Lancet Reg Health Eur, 66
CT radiomics for survival risk stratification in resectable colorectal liver metastases: a multi-centre study
Journal article
Mian A. et al, (2026), Scientific Reports, 16
Pragmatism in academic gastrointestinal cancer clinical trials: An analysis of trials conducted by the EORTC gastrointestinal tract cancer group and the unicancer gastrointestinal group.
Journal article
Puhr HC. et al, (2026), Eur J Cancer, 241
Supplementary Table 3 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 4 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 2 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 1 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 2 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 3 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Table 1 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Supplementary Figure 4 from The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine
Other
Hashimoto T. et al, (2026)
Blog posts
Meet Dr Wei-Ting Lu: Exploring Genome Instability in Cancer
Dr Wei-Ting Lu joined the Department of Oncology in September 2025, establishing a research group focused on chromosomal instability and whole genome doubling in cancer. In this blog, Dr Lu shares insights into his lab’s research and the discoveries, both his own and those of others, that sparked his interest in the field.
Beyond the Bench: Lauren's Journey From Cancer Research to Patent Law
After studying the MSc Applied Cancer Science in 2024-2025, Lauren Woodman began her career as a Trainee Patent Attorney. In this blog, she shares her experience of the course and how it inspired her interest in intellectual property law.
International Day of Women and Girls in Science 2026
Today, 11th Feb 2026, is International Day of Women and Girls in Science. To celebrate, our MSc Medical Physics/Radiobiology students honour five pioneering women who shaped nuclear medicine and inspired them on their own journeys in science.
Student Spotlight: Personalised Dosimetry for Radionuclide Therapy
Mark Macsuka is a Clarendon DPhil Scholar in Oncology working on personalised lutetium-177 (177Lu) dosimetry for radionuclide therapies. In this blog, Mark shares insights into the role of AI in cancer treatment and the potential for improved outcomes through personalised treatment approaches.
Staff Spotlight: Working as a Technician in the Translational Support Unit
Sruthi Shakthivel works as a technician in the Translational Support Unit (TSU), a dedicated unit within the Oncology Clinical Trials Office (OCTO) that focuses on the operational and scientific side of biological sample management in clinical trials. In this blog, Sruthi shares insights on the mission of the TSU, how they support clinical research teams, and what her role involves.